Innate and adaptive mucosal defense mechanisms ensure a homeostatic relationship with the large and complex mutualistic gut microbiota. Dimeric IgA and pentameric IgM are transported across the intestinal epithelium via the epithelial polymeric Ig receptor (pIgR) and provide a significant portion of the first line of natural or adaptive antibody-mediated immune defense of the intestinal mucosa. We found that colonic epithelial cells from pIgR KO mice differentially expressed (more than twofold change) more than 200 genes compared with cells from WT mice, and upregulated the expression of antimicrobial peptides in a commensal-dependent manner. Detailed profiling of microbial communities based on 16S rRNA genes revealed differences in the commensal microbiota between pIgR KO and WT mice. Furthermore, we found that pIgR KO mice showed increased susceptibility to dextran sulfate sodium-induced colitis, and that this was driven by their conventional intestinal microbiota. Thus, in the absence of pIgR, the stability of the commensal microbiota is disturbed, gut homeostasis is compromised, and the outcome of colitis is significantly worsened.

Download full-text PDF

Source
http://dx.doi.org/10.1002/eji.201242543DOI Listing

Publication Analysis

Top Keywords

pigr mice
12
polymeric receptor
8
commensal microbiota
8
mice
5
pigr
5
epithelial-microbial crosstalk
4
crosstalk polymeric
4
receptor deficient
4
deficient mice
4
mice innate
4

Similar Publications

IgA facilitates the persistence of the mucosal pathogen Helicobacter pylori.

Mucosal Immunol

November 2024

Institute of Molecular Cancer Research, University of Zürich, Zürich, Switzerland; Comprehensive Cancer Center Zürich, Zürich, Switzerland. Electronic address:

Article Synopsis
  • IgA antibodies play a crucial role in defending against mucosal pathogens like Helicobacter pylori and Citrobacter rodentium, with strong local IgA responses observed during infections.
  • The study shows that production of IgA involves various immune components, including Peyer's patches and specific T-cells, and is influenced by bacterial factors like type IV secretion systems.
  • Interestingly, while IgA helps control H. pylori effectively, its absence leads to severe infections and weight loss with C. rodentium, highlighting that IgA's effects can vary depending on the pathogen involved.*
View Article and Find Full Text PDF
Article Synopsis
  • This study explored how gut microbiota (GM) affects the development of gout and hyperuricemia using genetic data and experiments on mice.
  • Researchers used advanced statistical methods to predict the impact of GM on gout and identified specific GM taxa linked to the disease, as well as 38 immune cell traits associated with gout.
  • The findings revealed that changes in gut microbiome due to dysbiosis were related to alterations in serum metabolites and kidney gene expression, affecting vitamin B6 metabolism and leading to inflammation.
View Article and Find Full Text PDF
Article Synopsis
  • Colorectal cancer (CRC) has one of the highest mortality rates among cancers, and abnormal DNA methylation is a key factor in its progression.
  • Researchers identified a 3-CpG methylation signature linked to CRC prognosis, focusing on the gene FAM3D, which has not been thoroughly studied before.
  • Low expression and high methylation of FAM3D were found to be independent risk factors for CRC, as it promotes cancer cell growth and reduces sensitivity to common chemotherapy drugs by activating the mTORC1 pathway.
View Article and Find Full Text PDF

Background: Biliary atresia (BA) is a devastating neonatal cholangiopathy with an unclear pathogenesis, and prompt diagnosis of BA is currently challenging.

Methods: Proteomic and immunoassay analyses were performed with serum samples from 250 patients to find potential BA biomarkers. The expression features of polymeric immunoglobulin receptor (PIGR) were investigated using human biopsy samples, three different experimental mouse models, and cultured human biliary epithelial cells (BECs).

View Article and Find Full Text PDF

Antibodies and complement are key drivers of thrombosis.

Immunity

September 2024

Medizinische Klinik und Poliklinik I, University Hospital, LMU Munich, Munich, Germany; German Center for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Munich, Germany; Walter-Brendel Center of Experimental Medicine, Faculty of Medicine, LMU Munich, Munich, Germany.

Venous thromboembolism (VTE) is a common, deadly disease with an increasing incidence despite preventive efforts. Clinical observations have associated elevated antibody concentrations or antibody-based therapies with thrombotic events. However, how antibodies contribute to thrombosis is unknown.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!